By NewsDesk @bactiman63
The European Medicines Agency (EMA) and the Medical Products Agency are investigating reports of suspected side effects of blood clots in combination with bleeding in individuals vaccinated with Astra Zeneca’s covid-19 vaccine. The investigation examines the reports of suspected side effects that have been received in recent days to determine whether there is a causal link to the vaccine or not.
The suspected side effects have included blood clots (thrombosis) in combination with low levels of platelets (thrombocytopenia) in a few people. In Sweden, no such case has been reported so far.
It is a top priority that the vaccines used have a high safety profile, which is the reason why the Medical Products Agency and EMA are now investigating the suspected cases.
Astra Zeneca’s vaccine provides good protection against covid-19 and the total number of vaccine doses given amounts to 17 million.
There is good knowledge about the vaccine, but it is still important that we now pause the vaccination until the EMA has investigated whether these events may be related to vaccination, says Anders Tegnell.
The Swedish Public Health Agency cooperates with the Medical Products Agency in the matter and follows ongoing results from the investigation.
- Ebola in DRC: 1500 vaccinated, Healthcare providers threaten strike
- MRSA: KIMYRSA (oritavancin) receives FDA approval for treatment of ABSSSI
- Spain suspends AstraZeneca COVID-19 vaccine for the next two weeks
- Legionnaires’ Disease cluster reported in north New Jersey
- Salmonella outbreak grows in Sweden
- Norway reports blood clots in young people with the AstraZeneca vaccine
